Michael John Tomsicek - Chief Financial Officer at CRISPR Therapeutics AG

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
CRSP on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Michael John Tomsicek since 13 Sep 2025

Reported holdings for Michael John Tomsicek in CRISPR Therapeutics AG

Form 4 holding Chief Financial Officer

CRISPR Therapeutics AG

Security class
Common Shares
Shares / value
1,891
Estimated value
$118,193
Report date
06 Aug 2021
Price
$62.50
Ownership
Direct
Form 4 holding Chief Financial Officer

CRISPR Therapeutics AG

Security class
Stock Option (Right to Buy)
Shares / value
131,000
Estimated value
Report date
11 Mar 2021
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Transaction history for Michael John Tomsicek in CRISPR Therapeutics AG

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .